No increase in fracture incidence in patients treated for thyrotoxicosis in Malmo during 1970-74. A 20-year population-based follow-up

Journal of Internal Medicine

Volumn 246, Issue 2, 1999, Pages 139-144

  Hallengren, Bengt ^a   Elmstahl B ^a   Berglund, J ^a   Christensen, S B ^a   Elmstahl S ^a   Johnell, O ^a   Thorngren, K G ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fracture; Fragility fracture; Graves' disease; Thyrotoxicosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; SWEDEN; THYROTOXICOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; POPULATION SURVEILLANCE; REGISTRIES; SWEDEN; THYROTOXICOSIS;

EID: 0032775479     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00497.x     Document Type: Article

References (24)

1. Solomon BL, Wartofsky L, Burman KD. Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 1993; 3: 17-23.
2. Krolner B, Jörgensen V, Nielsen SP. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol (Oxf) 1983; 18: 439-46.
3. MacLeod JM, McHardy KC, Harvey RD et al. The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover. Clin Endocrinol (Oxf) 1993; 38: 49-53.
4. Fraser SA, Smith DA, Anderson JB, Wilson GM. Osteoporosis and fractures following thyrotoxicosis. Lancet 1971; i: 981-83.
5. Cummings SR, Nevitt MC, Browner WS et al. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767-73.
6. Wejda B, Hintze G, Katschinski B, Olbricht TH, Benker G. Hip fractures and the thyroid: a case-control study. J Intern Med 1995; 237: 241-47.
7. Berglund J, Christensen SB, Hallengren B. Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmö 1970-74. J Intern Med 1990; 227: 137-41.
8. Berglund J, Christensen SB, Dymling JF, Hallengren B. The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmö during the period 1970-74. J Intern Med 1991; 229: 435-42.
9. Breslow NE, Day NE. Statistical methods in cancer research. I: the analysis of case-control studies. IARC, Scientific Publications no. 32. Lyon: IARC, 1980.
10. Kelsey JL. Risk factors for osteopororis and associated fractures. Public Health Rep 1989; 104(Suppl.): 14-20.
11. Reid IR, Ames R, Evans MC et al. Determinants of total body and regional bone mineral density in normal postmenopausal women - a key role for fat mass. J Clin Endocrinol Metab 1992; 75: 45-51.
12. Ericsson UB, Lindgärde F. Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditils. J Intern Med 1991; 229: 67-71.
13. Fallon MD, Perry IIHM, Bergfeld M, Droke D, Teitelbaum SL, Avioli L. Exogenous hyperthyroidism with osteoporosis. Arch Intern Med 1983; 143: 442-44.
14. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MCK. Morbidity in patients on 1-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf) 1992; 37: 500-503.
15. Bayley TA, Harrison JE, McNeil KG, Mernagh JR. Effect of thyrotoxicosis and its treatment on bone mineral and muscle mass. J Clin Endocrinol Metab 1980; 50: 916-22.
16. Tob SH, Claunch BC, Brown PH. Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 1985; 145: 883-86.
17. Rosen CJ, Adler RA. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocrinol Metab 1992; 75: 1531-34.
18. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormone on bone and mineral metabolism. Endocrinol Metab Clin North Am 1990; 19: 35-63.
19. Diamond T, Vine J, Smart R, Butler P. Thyrotoxic bone disease in women: a potentially reversible disorder Ann Intern Med 1994; 120: 8-11.
20. Langdahl BI, Loft AGR, Eriksen EF, Mosekilde L, Charles P. Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Thyroid 1996; 6: 161-68.
21. Langdahl BI, Loft AGR, Eriksen EF, Mosekilde L, Charles P. Bone mass, bone turnover, calcium homeostasis and body composition in surgically and radioiodine-treated former hyperthyroid patients. Thyroid 1996; 6: 169-75.
22. Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol (Oxf) 1994; 41: 425-32.
23. Grant DJ, McMurdo MET, Mole PA, Paterson OR. Is previous hyperthyroidism still a risk factor for osteoporosis in postmenopausal women? Clin Endocrinol (Oxf) 1995; 43: 339-45.
24. 131I treatment on the calcitonin response to calcium infusion in hyperthyroid patients. Clin Endocrinol (Oxf) 1993; 38: 25-28.